Use of Dipeptidyl peptidase IV inhibitors for preventing, delaying or reducing the occurance of edema

Details for Australian Patent Application No. 2007318059 (hide)

Owner Novartis AG

Inventors Holmes, David Grenville; Balkan, Bork; Hughes, Thomas Edward; Villhauer, Edwin Bernard

Agent Davies Collison Cave

Pub. Number AU-A-2007318059

PCT Pub. Number WO2008/057337

Priority 60/863,816 01.11.06 US

Filing date 30 October 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/425 (2006.01) - Thiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/057337 Priority application(s): WO2008/057337

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318074-Magnetic flux leakage system and method

2007318058-Heterocyclyl-substituted antihypercholesterolemic compounds